This study emphasizes the importance of understanding NET markers and vWF levels of COVID-19 patients with thrombotic events in order to better inform the prevention of future thrombotic events due to coagulopathy in COVID-19 and other related illnesses. This evidence concerns the gene VWF and COVID-19.